Baystate Wealth Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $109 | Hold |
200
| – | – | ﹤0.01% | 1289 |
|
|
2023
Q3 | $120 | Hold |
200
| – | – | ﹤0.01% | 998 |
|
|
2023
Q2 | $260 | Hold |
200
| – | – | ﹤0.01% | 999 |
|
|
2023
Q1 | $352 | Hold |
200
| – | – | ﹤0.01% | 988 |
|
|
2022
Q4 | $1K | Hold |
200
| – | – | ﹤0.01% | 904 |
|
|
2022
Q3 | $1K | Hold |
200
| – | – | ﹤0.01% | 849 |
|
|
2022
Q2 | $1K | Hold |
200
| – | – | ﹤0.01% | 869 |
|
|
2022
Q1 | $1K | Hold |
200
| – | – | ﹤0.01% | 854 |
|
|
2021
Q4 | $2K | Hold |
200
| – | – | ﹤0.01% | 777 |
|
|
2021
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 701 |
|
|
2021
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 672 |
|
|
2021
Q1 | $3K | Hold |
200
| – | – | ﹤0.01% | 571 |
|
|
2020
Q4 | $3K | Hold |
200
| – | – | ﹤0.01% | 544 |
|
|
2020
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 550 |
|
|
2020
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 562 |
|
|
2020
Q1 | $1K | Buy |
+200
| New | +$1K | ﹤0.01% | 571 |
|